Novartis Institutes for BioMedical Research Revenue and Competitors

Our people\nWith more than 6,000 scientists, physicians and business professionals around the world, we have an open, entrepreneurial and innovative culture that encourages collaboration as we work to push the boundaries of science to change the practice of medicine. \n\nNIBR focuses on the following disease areas:\n\n• Autoimmunity, Transplantation, and Inflammatory Disease \n• Cardiovascular & Metabolic Diseases\n• Immuno-oncology\n• Infectious Diseases\n• Musculoskeletal Diseases\n• Neuroscience\n• Oncology\n• Ophthalmology\n• Respiratory Diseases\n\n\nNIBR has built expertise around several key technology competencies. Each competency combines automation and robotics, computational science, biology and irreplaceable drug discovery knowledge. By building expertise around key technologies, it can be more effectively applied across diseases that share similar mechanisms.\n\n• Analytical Sciences\n• Biologics\n• Biomarker Development\n• Chemistry\n• Developmental and Molecular Pathways\n• Drug Metabolism & Pharmacokinetics\n• Genomics Institute of the Novartis Research Foundation ›\n Developing advanced technologies, ranging from cellular genomics and proteomics to combinatorial \n chemistry and structural biology\n• Imaging\n• Metabolism and Pharmacokinetics\n• Preclinical Safety\n• Proteomic Chemistry\n• Translational Medicine\n\nNIBR has locations in:\n\n• Basel, Switzerland \n• Cambridge, MA \n• East Hanover, NJ\n• Emeryville, CA (SF Bay Area)\n• San Diego, CA\n• Shanghai, China\n\nThank you for taking an interest in the NIBR LinkedIn page. Please read Novartis' LinkedIn community guidelines: https://www.novartis.com/sites/www.novartis.com/files/linkedin-community-guidelines.pdf